BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Julphar
Farmers Insurance
Boehringer Ingelheim
Deloitte
Baxter
Cerilliant
Express Scripts
Harvard Business School

Generated: January 24, 2018

DrugPatentWatch Database Preview

NABUMETONE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nabumetone and what is the scope of nabumetone patent protection?

Nabumetone
is the generic ingredient in two branded drugs marketed by Apotex Inc, Chartwell Molecules, Copley Pharm, Dr Reddys Labs Ltd, Impax Labs Inc, Invagen Pharms, Lupin Ltd, Mylan Pharms Inc, Oxford Pharms, Sandoz, Watson Labs, and Smithkline Beecham, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for nabumetone. Forty-two suppliers are listed for this compound.
Pharmacology for NABUMETONE

US Patents and Regulatory Information for NABUMETONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham RELAFEN nabumetone TABLET;ORAL 019583-002 Dec 24, 1991 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz NABUMETONE nabumetone TABLET;ORAL 075590-002 Feb 25, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Invagen Pharms NABUMETONE nabumetone TABLET;ORAL 078671-002 Mar 7, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Oxford Pharms NABUMETONE nabumetone TABLET;ORAL 079093-002 Feb 27, 2009 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs NABUMETONE nabumetone TABLET;ORAL 091083-002 Jun 13, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Molecules NABUMETONE nabumetone TABLET;ORAL 076009-001 Jan 24, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Invagen Pharms NABUMETONE nabumetone TABLET;ORAL 078671-001 Mar 7, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc NABUMETONE nabumetone TABLET;ORAL 090516-001 Jul 12, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc NABUMETONE nabumetone TABLET;ORAL 090427-002 Dec 30, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd NABUMETONE nabumetone TABLET;ORAL 078420-001 Sep 24, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NABUMETONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham RELAFEN nabumetone TABLET;ORAL 019583-001 Dec 24, 1991 ➤ Subscribe ➤ Subscribe
Smithkline Beecham RELAFEN nabumetone TABLET;ORAL 019583-001 Dec 24, 1991 ➤ Subscribe ➤ Subscribe
Smithkline Beecham RELAFEN nabumetone TABLET;ORAL 019583-002 Dec 24, 1991 ➤ Subscribe ➤ Subscribe
Smithkline Beecham RELAFEN nabumetone TABLET;ORAL 019583-002 Dec 24, 1991 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cipla
Dow
Cerilliant
Moodys
McKesson
Queensland Health
US Army
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot